Monashee Investment Management »

Urogen Pharma shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $699k 55k 12.70
2024-06-30 $680k 41k 16.78
2017-09-30 $594k 33k 18.05
2017-06-30 $594k 33k 18.05

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Casella Waste Sys Cl A (CWST)
Aercap Holdings Nv SHS (AER)
Viking Holdings Ord Shs (VIK)
American Healthcare Reit Com Shs (AHR)
Lineage
Sable Offshore Corp Com Shs (SOC)
Newmont Mining Corporation (NEM)

View all positions for Monashee Investment Management

Top funds holding Urogen Pharma

BlackRock
BlackRock
Morgan Stanley
Cowen And Company
Cormorant Asset Management
Point72 Asset Management
Silverarc Capital Management
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
State Street Corporation
Migdal Insurance & Financial Holdings
Wildcat Capital Management
Harel Insurance Investments & Financial Services
DAFNA Capital Management
Geode Capital Management

View all funds holding Urogen Pharma